tiprankstipranks
Advertisement
Advertisement
Roivant Sciences reports Q1 EPS (26c), consensus (36c)
PremiumThe FlyRoivant Sciences reports Q1 EPS (26c), consensus (36c)
6d ago
Roivant Sciences price target raised to $35 from $31.50 at BofA
Premium
The Fly
Roivant Sciences price target raised to $35 from $31.50 at BofA
12d ago
Arbutus initiates patent infringement actions against Pfizer, BioNTech
Premium
The Fly
Arbutus initiates patent infringement actions against Pfizer, BioNTech
27d ago
Roivant Sciences price target raised to $42 from $35 at Citi
PremiumThe FlyRoivant Sciences price target raised to $42 from $35 at Citi
3M ago
Roivant Sciences Earnings Call Highlights High-Impact Pipeline
Premium
Company Announcements
Roivant Sciences Earnings Call Highlights High-Impact Pipeline
3M ago
Roivant Sciences rises 15.2%
Premium
The Fly
Roivant Sciences rises 15.2%
3M ago
Roivant Sciences price target raised to $29.50 from $29 at BofA
PremiumThe FlyRoivant Sciences price target raised to $29.50 from $29 at BofA
3M ago
SiTime, Photronics, Icici, Roivant, Marqeta Shake Markets
Premium
Weekend Updates
SiTime, Photronics, Icici, Roivant, Marqeta Shake Markets
4M ago
Roivant Sciences participates in a conference call with JPMorgan
Premium
The Fly
Roivant Sciences participates in a conference call with JPMorgan
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100